To determine the expression of inflammation-and pain-related genes at days 1 and 3 in the dorsal root ganglion (DRG) of rats with or without disc puncture, using real-time quantitative polymerase chain reaction (RT-qPCR) with the TaqMan low-density array (TLDA). Methods. 53 female Sprague-Dawley rats were used. The left facet joint between L4 and L5 was removed, and the DRG and intervertebral disc between the vertebrae were exposed. The L4-5 intervertebral disc was punctured using a 0.4-mm diameter injection needle (disc puncture group) or left unpunctured (sham group). After one or 3 days, the 53 DRGs were harvested, frozen, and assessed for expression of inflammation-related genes. Total RNA was isolated from the DRGs. Expression of 119 genes related to inflammation and pain in the DRG after disc puncture were analysed using RT-qPCR with the TLDA. Results. Of the 95 inflammation-related genes, 78 genes were reliably detected. Two genes were significantly up-regulated: cysteinyl leukotriene receptor 1 (CYSLTR1) at day 3 and interleukin 2 receptor gamma (IL2RG) at day 1, and one gene was significantly down-regulated: phospholipase C beta 3 (PLCB3) at day 1. Of the 24 pain-related genes, 18 genes were reliably detected. Two genes were significantly up-regulated: nitric oxide synthase 1 (NOS1) at days 1 and 3 and 5-HT2A receptor (HTR2A) at day 1. Conclusion. Disc puncture may elicit changes in the expression of a variety of genes. Gene expression profiling is a useful tool for detecting new potential pharmaceutical targets for spinal pain syndromes.
nucleus pulposus that induces biochemical irritation of the nearby nerve root. 2, 3 The nucleus pulposusmediated nerve root injury is mediated via cytokines, especially tumour necrosis factor (TNF). 4 Thus, clinical trials of TNF inhibition for sciatica are aimed directly at the cause of the pain. 5 However, most TNFinhibitors display unwanted side effects. 6 This study aimed to determine expression of inflammation-and pain-related genes at days 1 and 3 in the dorsal root ganglion (DRG) of rats with or without disc puncture, using real-time quantitative polymerase chain reaction (RT-qPCR) with the TaqMan low-density array (TLDA).
Materials and Methods
This study was approved by the ethics committee of our hospital. 53 female Sprague-Dawley rats (mean weight, 225 g) were used. The rats were anaesthetised by inhalation of isoflurane, followed by an intramuscular injection of 0.04 ml of buprenorphine 10 minutes before surgery. The left facet joint between L4 and L5 was removed, and the DRG and intervertebral disc between the vertebrae were exposed. The L4-5 intervertebral disc was punctured using a 0.4-mm diameter injection needle (disc puncture group) or left unpunctured (sham group).
After one or 3 days, the 53 DRGs were harvested, frozen, and assessed for expression of inflammationrelated genes: sham day 1 (n=3) and day 3 (n=5), disc puncture day 1 (n=5) and day 3 (n=5), and no-surgery controls (n=16), as well as for expression of painrelated genes: sham day 1 (n=5) and day 3 (n=5), disc puncture day 1 (n=4) and day 3 (n=5), and no-surgery controls (n=10).
Total RNA was isolated from the DRGs, with an aim to maximise the number of biological samples rather than technical replicates. 7 The RNA concentrations were spectrophotometrically measured. 1 μg of total RNA was reverse transcribed in a 20 μl final reaction volume. The thermal cycling condition was 25ºC for 5 minutes, 42ºC for 30 minutes, and 85ºC for 5 minutes. RT-qPCR was performed using the TLDA. A total of 5 ng cDNA together with TaqMan gene expression master mix were loaded to a final volume of 100 μl into 96-well plates. 8, 9 All samples were run as duplicates. The thermal cycling condition was 50ºC for 2 minutes and 95ºC for 10 minutes, followed by 40 cycles of amplification (97ºC for 30 seconds and 60ºC for 1 minute).
Inflammation-related genes were assessed using TLDA microfluidic cards pre-printed with 96 genes (Table 1), whereas pain-related genes were assessed  using customised TLDA cards with 24 genes related  to pain transmission (Table 2) .
Gene expression was analysed. [10] [11] [12] Briefly, potential reference genes were identified with NormFinder. Inflammatory-related genes were normalised against beta-actin (ACTB), arachidonate 12-lipoxygenase (ALOX12), leukotriene A4 hydrolase (LTA4H), mitogen activated protein kinase 14 (MAPK14), nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1), nuclear receptor subfamily 3C1 (NR3C1), and phospholipase C-gamma 1 (PLCG1). The pain-related genes were normalised against 18S ribosomal RNA (18S), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hypoxanthine phosphoribosyltransferase 1 (Hprt1), ribosomal protein large P2 (RPLP2), and sodium channel voltage-gated type III alpha (SCN3A). Cycle of quantification values were determined at a common threshold line for all genes, which were checked manually to be in the exponential phase of the amplification curve for all genes. All plates contained all genes, including reference genes, eliminating the need for inter-plate calibration. Missing data owing to low/no expression was replaced with the maximum measured cycle of quantification value plus 2 for the respective gene after normalisation. 10, 11 Relative quantities were calculated assuming 100% PCR efficiency for all genes. The value of the controls was arbitrarily set to a value of one. Relative quantities were transformed into log2-scale before comparing sham samples with disc puncture samples at days 1 and 3, using the Student's t-test with Holm-Bonferroni correction.12 A p value of <0.05 was considered statistically significant.
results
Of the 95 inflammation-related genes including 7 potential reference genes, 78 genes were reliably detected ( Table 1 ). In the disc puncture group, 2 genes were significantly up-regulated: cysteinyl leukotriene receptor 1 (CYSLTR1) at day 3 and interleukin 2 receptor gamma (IL2RG) at day 1, and one gene was significantly down-regulated: phospholipase C beta 3 (PLCB3) at day 1 ( Fig.) .
Of the 24 pain-related genes including 5 potential reference genes, 19 genes were reliably detected ( Table 2 ). In the disc puncture group, 2 genes were significantly up-regulated: nitric oxide synthase 1 (NOS1) at days 1 and 3 and 5-HT2A receptor (HTR2A) at day 1 ( Fig.) .
Gene
Gene symbol 
Table 2 Relative expression of pain-related genes in log 2 -scale

Figure
Relative expression of genes that were significantly up-or down-regulated: 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A), nitric oxide synthase 1 (NOS1), cysteinyl leukotriene receptor 1 (CYSLTR1), interleukin 2 receptor gamma (IL2RG), and phospholipase C beta 3 (PLCB3). discussion Disc puncture, without deformation of spinal nervous tissue, can result in pain. [13] [14] [15] Microarrays have been used to profile expression of genes in the peripheral nervous system of rodents following a variety of neuropathic and inflammatory pain states. 16 In our study, RT-qPCR with TLDA was used to detect significant changes in expression of inflammationand pain-related genes: CYSLTR1, IL2RG, PLCB3, NOS1, and HTR2A. CYSLTR1 is a member of the G protein-coupled receptors for leukotriene, 17, 18 which are involved in inflammatory pain. 19 The functional role of CYSLTR1 and tissue distribution of CYSLTR1 in the DRG remain largely unknown. 20 CYSLTR1 is the molecular target of anti-asthmatic drugs such as montelukast, zafirlukast, and pranlukast that have anti-inflammatory actions, but there is no evidence to support the use of these drugs for spinal pain.
IL2RG is a component of the receptors for IL-2, IL-4, IL-7, IL-9, and IL-15. It is expressed on the surface of neutrophils and is critical for the development and function of lymphocytes. 21 PLCB3 is an isoform of the phospholipase C family, which is linked to membrane receptors through isoform-specific mechanisms. PLCB3 has been found in small-diameter, presumptive nociceptor, DRG neurons of rats. 22 PLCB3 is upstream of the protein kinase C epsilon that contributes to inflammatory pain.
NOS1 is an isoform of nitric oxide synthase and is associated with nociception, inflammatory, and neuropathic pain in the DRG. 23 NOS1 was up-regulated at days 1 and 3 in DRG following disc puncture; it might serve as a therapeutic target for lumbar disc herniation. It is not known whether inhibitors of NOS1, such as L-NG-Nitroarginine methyl ester (L-NAME), are useful for low back pain and sciatica.
HTR2A is mainly expressed in small neurons in the DRG and is involved in the potentiation of inflammatory pain. 24 The use of HTR2A antagonists has been shown to improve sciatica in patients with lumbar disc herniation. 25 Further studies of other genes in the same pathways up-stream and down-stream are needed. In addition, studies of gene expression for other durations and for other trauma types (such as a combination of nucleus pulposus exposure and mechanical deformation that mimics the effects of sciatica due to a herniated disc), as well as studies exploring the association between protein levels and the genes expressed in various spinal conditions are warranted.
conclusion Disc puncture may elicit changes in the expression of a variety of genes. Gene expression profiling is a useful tool for detecting new potential pharmaceutical targets for spinal pain syndromes.
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